A little-known protein could be a major culprit in type 2 diabetes
Researchers have identified a protein called Miro1 that interferes with insulin response in skeletal muscles, contributing to Type 2 diabetes. Removing this protein in experiments restored insulin sensitivity, suggesting a potential new target for diabetes treatments.
Why it matters
Understanding the biological mechanisms of insulin resistance could lead to more effective therapies for managing Type 2 diabetes.
Researchers have identified a protein that may play an important role in Type 2 diabetes by interfering with the body's ability to respond to insulin. The discovery could provide a promising new target for treatments designed to improve blood sugar control.
The protein, known as Miro1, was found at higher levels in the skeletal muscles of people with Type 2 diabetes. In preclinical experiments, scientists discovered that removing Miro1 restored the muscles' response to insulin. They also found that exercise lowered Miro1 levels in people with the disease, offering new insight into how physical activity improves insulin sensitivity.
The findings were published in Nature Communications and could help researchers better understand the biological processes behind insulin resistance, a central feature of Type 2 diabetes.
How a Hidden Muscle Protein Affects Insulin Resistance
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in